Jan Sahai

1.5k total citations
35 papers, 1.1k citations indexed

About

Jan Sahai is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Jan Sahai has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 19 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Jan Sahai's work include HIV/AIDS drug development and treatment (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers) and HIV Research and Treatment (8 papers). Jan Sahai is often cited by papers focused on HIV/AIDS drug development and treatment (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers) and HIV Research and Treatment (8 papers). Jan Sahai collaborates with scholars based in Canada, United States and Hong Kong. Jan Sahai's co-authors include Daniel P. Healy, Ron E. Polk, Keith Gallicano, D. William Cameron, Gary Garber, Daniel Sitar, Nanci Hawley‐Foss, Stephen J. Ruberg, Mark Shelton and A R Berry and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Jan Sahai

34 papers receiving 1.0k citations

Peers

Jan Sahai

EPIDE

PHARM

ONCOL

Bharat Damle United States

R. Garraffo France

Giorgio Gatti Italy

Lorena Baietto Italy

Emmanuel Chigutsa United States

A. K. Hemanth Kumar India

Edward O’Mara United States

Anne M. Baciewicz United States

Lillian Ting Canada

Odin Naderer United States

Bharat Damle United States

Jan Sahai

1.0k ×1.9

418 ×1.2

EPIDE

344 ×1.0

PHARM

305 ×1.8

ONCOL

196 ×1.4

Citations per year, relative to Jan Sahai Jan Sahai (= 1×) peers Bharat Damle

Countries citing papers authored by Jan Sahai

Since Specialization

Citations

This map shows the geographic impact of Jan Sahai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Sahai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Sahai more than expected).

Fields of papers citing papers by Jan Sahai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Sahai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Sahai. The network helps show where Jan Sahai may publish in the future.

Co-authorship network of co-authors of Jan Sahai

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Sahai. A scholar is included among the top collaborators of Jan Sahai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Sahai. Jan Sahai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doranz, Benjamin J., L G Filion, Francisco Díaz‐Mitoma, et al.. (2001). Safe Use of the CXCR4 Inhibitor ALX40-4C in Humans. AIDS Research and Human Retroviruses. 17(6). 475–486. 89 indexed citations

Gallicano, Keith, Jan Sahai, Vijay K. Shukla, et al.. (1999). Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV‐infected patients. British Journal of Clinical Pharmacology. 48(2). 168–179. 66 indexed citations

Choudhri, Shurjeel H, Mark Hawken, Samuel Gathua, et al.. (1997). Pharmacokinetics of Antimycobacterial Drugs in Patients with Tuberculosis, AIDS, and Diarrhea. Clinical Infectious Diseases. 25(1). 104–111. 68 indexed citations

Payette, Paul, et al.. (1997). Development of an enzyme-linked immunosorbent assay for measurement of serum-associated ALX40-4C. Clinical and Diagnostic Laboratory Immunology. 4(6). 671–675. 1 indexed citations

Gallicano, Keith & Jan Sahai. (1996). Lack of gender effect on ciprofloxacin pharmacokinetics in humans. British Journal of Clinical Pharmacology. 42(5). 632–634. 7 indexed citations

Sahai, Jan, et al.. (1996). Reduced Oral Absorption of Tuberculosis Drugs in HIV Infection. Clinical Pharmacology & Therapeutics. 59(2). 142–142. 6 indexed citations

Gallicano, Keith, et al.. (1995). Effect of Rifabutin on the Pharmacokinetics of Zidovudine in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 21(4). 1008–1008. 8 indexed citations

Sahai, Jan, et al.. (1995). Pharmacokinetics of Simultaneously Administered Zidovudine and Didanosine in HIV-Seropositive Male Patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 10(1). 54???60–54???60. 6 indexed citations

Sahai, Jan, Keith Gallicano, Eric Ormsby, Gary Garber, & D. William Cameron. (1994). Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients. AIDS. 8(6). 793–796. 8 indexed citations

10.

Sahai, Jan, et al.. (1994). Effect of Fluconazole on Zidovudine Pharmacokinetics in Patients Infected with Human Immunodeficiency Virus. The Journal of Infectious Diseases. 169(5). 1103–1107. 72 indexed citations

11.

Sahai, Jan, et al.. (1993). Cations in the didanosine tablet reduce ciprofloxacin bioavailability. Clinical Pharmacology & Therapeutics. 53(3). 292–297. 52 indexed citations

12.

Gallicano, Keith, et al.. (1993). Pharmacokinetics of zidovudine after the initial single dose and during chronic‐dose therapy in HIV‐infected patients.. British Journal of Clinical Pharmacology. 36(2). 128–131. 11 indexed citations

13.

Sahai, Jan & Stan G. Louie. (1993). Overview of the Immune and Hematopoietic Systems. American Journal of Health-System Pharmacy. 50(7_Suppl). S4–S11. 3 indexed citations

14.

Conway, Barbara R., et al.. (1993). Letrazuril therapy for cryptosporidiosis. AIDS. 7(3). 438–439. 2 indexed citations

15.

Sahai, Jan, Keith Gallicano, Gary Garber, et al.. (1992). Evaluation of the in vivo effect of naproxen on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus. Clinical Pharmacology & Therapeutics. 52(5). 464–470. 8 indexed citations

16.

Sahai, Jan, et al.. (1990). Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome". Antimicrobial Agents and Chemotherapy. 34(5). 765–769. 65 indexed citations

17.

Sahai, Jan, et al.. (1989). Eflornithine for the Treatment of Pneumocystis carinii Pneumonia in Patients with the Acquired Immunodeficiency Syndrome: A Preliminary Review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(1). 29–33. 11 indexed citations

18.

Sahai, Jan, et al.. (1989). Influence of Antihistamine Pretreatment on Vancomycin-Induced Red-Man Syndrome. The Journal of Infectious Diseases. 160(5). 876–881. 54 indexed citations

19.

Polk, Ron E., et al.. (1989). Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers. Antimicrobial Agents and Chemotherapy. 33(11). 1841–1844. 124 indexed citations

20.

Sahai, Jan, et al.. (1988). Sulfadiazine-induced crystalluria in a patient with the acquired immunodeficiency syndrome: a reminder. The American Journal of Medicine. 84(4). 791–792. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact